Post-approval studies (Phase 4)Study completedNCT00090207
What this trial is testing
Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)
Who this might be right for
NauseaVomiting
Merck Sharp & Dohme LLC 477